Toggle navigation
Home
Search
Services
Blog
Contact
About
Mammalian Expression of Neo-Proteoglycan Gene
Mann, David M.
Sanford-Burnham Medical Research Institute, La Jolla, CA, United States
Search 63 grants from David Mann
Search grants from Sanford-Burnham Medical Research Institute
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
A Novel Tolerance Therapeutic for Treating Multiple Sclerosis
Hearing Loss and Aging
Predoctoral Training in Cell and Molecular Biology
Alcohol/Adenosine Transporters - Role of Phosphorylation
Subchronic and Chronic Studies of Oxazepam
Recently added grants:
Developing novel combination therapies for pancreatic cancer
SUMO1 inhibition compound as a new anticancer drug for glioblastoma therapy
Notch and GATA-3 as novel therapeutic targets in T-cell lymphomas
Intraoperative Parathyroid Localization Using DOCI
Copy Number Alterations in Low Mutation Cancer
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32CA008646-01
Application #
3033883
Study Section
(BI)
Project Start
1989-03-20
Project End
Budget Start
1988-10-01
Budget End
1989-09-30
Support Year
1
Fiscal Year
1988
Total Cost
Indirect Cost
Institution
Name
Sanford-Burnham Medical Research Institute
Department
Type
DUNS #
009214214
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Related projects
NIH 1989
F32 CA
Mammalian Expression of Neo-Proteoglycan Gene
Mann, David M. / Sanford-Burnham Medical Research Institute
NIH 1988
F32 CA
Mammalian Expression of Neo-Proteoglycan Gene
Mann, David M. / Sanford-Burnham Medical Research Institute
Publications
Ge, Lin; Meng, Wenxia; Zhou, Hongmei et al.
(2010)
Could stroma contribute to field cancerization?
Med Hypotheses 75:26-31
Comments
Be the first to comment on this grant